Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

LEO Pharma has reported outcomes from the 16-week interim analysis of the Phase IIIb ADHAND trial of tralokinumab for hand atopic dermatitis (AD).

The trial aims to assess the safety and efficacy of tralokinumab 300mg administered biweekly as a single agent.

Life in the Cairo and Giza governorates, home to 20 million Egyptians, was thrown into disarray this week after a fire broke out at the Ramses Central Exchange, one of Egypt’s largest ...